在动脉样硬化心血管疾病中训练免疫力
Niels P Riksen1, Siroon Bekkering2, Willem J M Mulder2,3
1Department of Internal Medicine and Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. niels.riksen@radboudumc.nl.
Nature reviews. Cardiology
|June 15, 2023
概括
训练有素的免疫力或天生的免疫记忆,有助于动脉样硬化心血管疾病的慢性炎症. 了解它的机制可能会导致这种疾病的新疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 心血管科学 心血管科学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 训练有素的免疫力是一种先天性免疫记忆形式,涉及先天性免疫细胞的持续超响应.
- 这种现象越来越多地与动脉样硬化心血管疾病 (ASCVD) 中的慢性炎症有关.
- 内源性因素,如修饰性脂蛋白和高血糖,以及生活方式和并发症,可以诱导训练免疫力.
研究的目的:
- 在ASCVD的背景下,审查训练免疫的分子和细胞机制.
- 探索骨髓造血干细胞在系统调节中的作用.
- 讨论在ASCVD中调节训练免疫力的治疗策略.
主要方法:
- 关于训练免疫和动脉样硬化心血管疾病的当前文献的综述.
- 对髓状细胞中的分子和表观遗传重编程的分析.
- 通过造血原生细胞检查系统调节.
主要成果:
- 训练有素的免疫力是由心血管疾病风险因素激活的,包括生活方式选择和并发症.
- 机制包括骨髓状细胞的代谢和表观遗传重编程.
- 训练有素的免疫表现出多样化的细胞参与和潜在的跨代遗传等特征.
结论:
- 训练有素的免疫力是动脉样硬化心血管疾病的发病过程中的关键因素.
- 训练免疫的治疗向对ASCVD的管理具有前景.
- 对其机制和遗传的进一步研究是有必要的.
相关概念视频
Atherosclerosis I: Introduction
13
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
13
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
16
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
16
Inflammation
54.0K
Overview
54.0K
Atherosclerosis III: Management
15
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15
Coronary Artery Disease II: Pathophysiology
15
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
15
Psychoneuroimmunology: Cardiovascular Disease
56
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
56


